» Articles » PMID: 27999622

Purification, Characterization and Comparison Between Two New L-asparaginases from PG03 and PG04

Overview
Journal Open Biochem J
Publisher Bentham Open
Specialty Biochemistry
Date 2016 Dec 22
PMID 27999622
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: L-asparaginase has been used as a chemotherapeutic agent in treatment of lymphoblastic leukemia. In the present investigation, sp. PG03 and sp. PG04 were studied.

Methods: L- asparaginases were produced using different culture media and were purified using ion exchange chromatography.

Results: Maximum productivity was obtained when asparagine was used as the nitrogen source at pH 7 and 48 h after cultivation. New intracellular L-asparaginases showed an apparent molecular weight of 25 kDa and 30 kDa by SDS-PAGE respectively. These enzymes were active in a wide pH range (3-9) with maximum activity at pH 6 for PG03 and pH 7 for PG04 L-asparaginase. PG03 enzyme was optimally active at 37 ˚C and PG04 maximum activity was observed at 40˚C. Kinetic parameters and of both enzymes were studied using L-asparagine as the substrate. Thermal inactivation studies of PG03 and PG04 L-asparaginase exhibited t of 69.3 min and 34.6 min in 37 ˚C respectively. Also T and ∆G of inactivation were measured for both enzymes.

Conclusion: The results revealed that both enzymes had appropriate characteristics and thus could be a potential candidate for medical applications.

Citing Articles

The structural insights of L-asparaginase from CSPS4 at elevated temperatures highlight its thermophilic nature.

Kumar V, Anand P, Srivastava A, Akhter Y, Verma D 3 Biotech. 2024; 14(10):230.

PMID: 39280800 PMC: 11391003. DOI: 10.1007/s13205-024-04072-w.


Production of highly cytotoxic and low immunogenic L-asparaginase from Stenotrophomonas maltophilia EMCC2297.

Abdelrazek N, Saleh S, Raafat M, Ali A, Aboulwafa M AMB Express. 2024; 14(1):51.

PMID: 38704453 PMC: 11069494. DOI: 10.1186/s13568-024-01700-9.


Thermostable bacterial L-asparaginase for polyacrylamide inhibition and in silico mutational analysis.

Sundaram S, Kannan A, Chintaluri P, Ganapathy Vilasam Sreekala A, Nathan V Int Microbiol. 2024; 27(6):1765-1779.

PMID: 38519776 DOI: 10.1007/s10123-024-00493-y.


Characterization of a Type II L-Asparaginase from the Halotolerant CH11.

Arredondo-Nunez A, Monteiro G, Flores-Fernandez C, Antenucci L, Permi P, Zavaleta A Life (Basel). 2023; 13(11).

PMID: 38004285 PMC: 10672034. DOI: 10.3390/life13112145.


Production and Anticancer Activity of an L-Asparaginase from Bacillus licheniformis Isolated from the Red Sea, Saudi Arabia.

Alrumman S, Mostafa Y, Al-Izran K, Alfaifi M, Taha T, Elbehairi S Sci Rep. 2019; 9(1):3756.

PMID: 30842557 PMC: 6403232. DOI: 10.1038/s41598-019-40512-x.

References
1.
Miller H, SALSER J, BALIS M . Amino acid levels following L-asparagine amidohydrolase (EC.3.5.1.1) therapy. Cancer Res. 1969; 29(1):183-7. View

2.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

3.
Cappelletti D, Chiarelli L, Pasquetto M, Stivala S, Valentini G, Scotti C . Helicobacter pyloril-asparaginase: a promising chemotherapeutic agent. Biochem Biophys Res Commun. 2008; 377(4):1222-6. DOI: 10.1016/j.bbrc.2008.10.118. View

4.
Amena S, Vishalakshi N, Prabhakar M, Dayanand A, Lingappa K . Production, purification and characterization of l-asparaginase from streptomyces gulbargensis. Braz J Microbiol. 2013; 41(1):173-8. PMC: 3768618. DOI: 10.1590/S1517-838220100001000025. View

5.
Kumar S, Dasu V, Pakshirajan K . Studies on pH and thermal stability of novel purified L-asparaginase from Pectobacterium carotojorum MTCC 1428. Mikrobiologiia. 2011; 80(3):349-55. View